Prenetics Global Limited - Class A Ordinary Share (PRE) closed at $16.33 on November 17, 2026, up 5.5% from the previous close, on volume of 214,648 shares (30-day average 189,916).
Data as of November 17, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 17, 2026. See the largest for 5, 30, 60 and 90 days
Prenetics Reports Q3 2026 Revenue Growth Led by IM8
TipRanks (Wed, 18-Nov 8:30 AM ET)
Prenetics Global reports Q3 results
Seeking Alpha News (Wed, 18-Nov 8:09 AM ET)
Globe Newswire (Wed, 18-Nov 8:01 AM ET)
Here are the major earnings before the open Wednesday
Seeking Alpha News (Tue, 17-Nov 6:00 PM ET)
Prenetics Global Q3 2026 Earnings Preview
Seeking Alpha News (Tue, 17-Nov 12:05 PM ET)
Prenetics Announces Diplo as IM8 Global Ambassador and Shareholder
TipRanks (Tue, 17-Nov 11:04 AM ET)
Globe Newswire (Mon, 16-Nov 8:30 AM ET)
Care Bears And Prenetics' IM8 Announce Global Partnership
PRNewswire (Thu, 5-Nov 8:33 AM ET)
Globe Newswire (Thu, 5-Nov 8:30 AM ET)
Prenetics' IM8 Names Brian J. Rosin as Successor Chief Financial Officer
Globe Newswire (Tue, 3-Nov 9:05 AM ET)
Prenetics Global Ltd is a consumer health and wellness company offering nutrition and longevity products through its flagship brand, IM8. It offers science-backed daily nutrition and longevity products distributed directly to consumers across multiple countries. The company's products are developed with scientific input and are subject to third-party quality certifications.
Prenetics Global Limited - Class A Ordinary Share trades on the NASDAQ stock market under the symbol PRE.
As of November 18, 2026, PRE stock price declined to $10.04 with 963,062 million shares trading.
PRE has a beta of 0.16, meaning it tends to be less sensitive to market movements. PRE has a correlation of 0.00 to the broad based SPY ETF.
PRE has a market cap of $168.46 million. This is considered a Micro Cap stock.
Last quarter Prenetics Global Limited - Class A Ordinary Share reported $46 million in Revenue and -$.53 earnings per share. This fell short of revenue expectation by $-3 million and missed earnings estimates by -$.08.
In the last 3 years, PRE traded as high as $27.24 and as low as $2.85.
The top ETF exchange traded funds that PRE belongs to (by Net Assets): GWX.
PRE has underperformed the market in the last year with a price return of -14.8% while the SPY ETF gained +11.2%. PRE has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -48.2% and -38.0%, respectively, while the SPY returned -4.9% and -2.8%, respectively.
PRE support price is $15.27 and resistance is $17.39 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PRE shares will trade within this expected range on the day.